Clarkston Capital Partners LLC Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Clarkston Capital Partners LLC lifted its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 60.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 24,000 shares of the medical research company’s stock after acquiring an additional 9,000 shares during the quarter. Clarkston Capital Partners LLC’s holdings in IQVIA were worth $4,716,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Pine Valley Investments Ltd Liability Co grew its holdings in shares of IQVIA by 0.5% during the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 9,481 shares of the medical research company’s stock valued at $2,247,000 after purchasing an additional 50 shares during the last quarter. Howard Capital Management Inc. grew its stake in shares of IQVIA by 4.9% during the fourth quarter. Howard Capital Management Inc. now owns 1,147 shares of the medical research company’s stock valued at $225,000 after buying an additional 54 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of IQVIA by 1.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 5,434 shares of the medical research company’s stock worth $1,068,000 after buying an additional 56 shares during the period. Cypress Wealth Services LLC lifted its stake in shares of IQVIA by 4.8% in the 4th quarter. Cypress Wealth Services LLC now owns 1,243 shares of the medical research company’s stock valued at $244,000 after acquiring an additional 57 shares during the last quarter. Finally, Harbor Investment Advisory LLC boosted its holdings in IQVIA by 4.7% during the 4th quarter. Harbor Investment Advisory LLC now owns 1,286 shares of the medical research company’s stock valued at $253,000 after acquiring an additional 58 shares during the period. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Stock Performance

Shares of IQV stock opened at $154.63 on Friday. The company’s fifty day moving average price is $189.67 and its 200-day moving average price is $203.82. The stock has a market cap of $27.26 billion, a PE ratio of 20.62, a price-to-earnings-growth ratio of 1.99 and a beta of 1.46. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 2.12. IQVIA Holdings Inc. has a 12 month low of $154.35 and a 12 month high of $252.88.

IQVIA (NYSE:IQV) last posted its quarterly earnings data on Thursday, February 6th. The medical research company reported $2.90 EPS for the quarter, missing the consensus estimate of $3.11 by ($0.21). IQVIA had a return on equity of 28.81% and a net margin of 8.91%. On average, equities analysts expect that IQVIA Holdings Inc. will post 10.84 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on IQV shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $270.00 price target on shares of IQVIA in a research note on Monday, February 10th. William Blair reiterated an “outperform” rating on shares of IQVIA in a report on Wednesday, December 11th. JPMorgan Chase & Co. dropped their price target on shares of IQVIA from $240.00 to $232.00 and set an “overweight” rating for the company in a research report on Tuesday, February 18th. Stephens assumed coverage on shares of IQVIA in a research report on Friday, December 20th. They issued an “overweight” rating and a $250.00 price objective on the stock. Finally, Truist Financial reissued a “buy” rating and issued a $263.00 target price (up from $261.00) on shares of IQVIA in a research note on Monday, February 10th. Five research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $249.05.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.